| 86R11009 JSC-D  
---|---  
|  By: Ramos | H.B. No. 1710  
---  
|  A BILL TO BE ENTITLED  
|  AN ACT  
| relating to discussing with a patient the risks of certain  
| controlled substance prescriptions.  
|  BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:  
|  SECTION 1. Section 481.0764, Health and Safety Code, is  
| amended by adding Subsections (f) and (g) to read as follows:  
|  _(f)_ _____A prescriber, other than a veterinarian, on issuance of_  
| _the initial prescription for a Schedule II controlled substance or_  
| _an opioid, shall discuss with the patient and, if the patient is a_  
| _minor, the patient's parent, conservator, or guardian, or other_  
| _person authorized to consent to the minor's medical treatment:_  
|  _(1)_ _____the risk of addiction associated with the drug_  
| _prescribed, including any risk of developing a physical or_  
| _psychological dependence on the drug;_  
|  _(2)_ _____the risk of overdose associated with the drug_  
| _prescribed; and_  
|  _(3)_ _____the danger of taking the drug with_  
| _benzodiazepines, alcohol, or other central nervous system_  
| _depressants._  
|  _(g)_ _____A prescriber who discusses the risks of a controlled_  
| _substance prescription under Subsection (f) shall note the_  
| _discussion in the patient's medical record._  
|  SECTION 2. The change in law made by this Act applies only  
| to a prescription issued on or after the effective date of this Act.  
| A prescription issued before the effective date of this Act is  
| governed by the law in effect on the date the prescription is  
| issued, and the former law is continued in effect for that purpose.  
|  SECTION 3. This Act takes effect September 1, 2019.

